Because of its high prevalence in conjunction with obesity, diabetes, and insulin resistance, NAFLD has been increasingly appreciated as a hepatic manifestation of metabolic syndrome and is the leading cause of death from liver disease in the United States 1,2,3
10 Minute Active Aging, led by Debbie Siebers, is a collection of 15 workouts focused on mobility, balance and functional strength for individuals over 60
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)
Most of the unproven peptides promoted online are technically being sold illegally
Anti-obesity drug discovery: advances and challenges
Save this for your hepatology revision Share it with your co fellows Follow @gastrowiser for board ready gastroenterology Hepcludex (bulevirtide) FDA approved May 2026 first approved treatment for chronic HDV To view or add a comment, sign in Adaptive inhibitor of viral infection - a fantastic study from our secondee, Pedro J
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
